Aprogen Medicines Inc. (KRX: 007460)

Aprogen Medicines Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	43,403	35,684	43,070	15,894	96,616	71,672
Short-Term Investments	-	-	-	4,000	-	-
Trading Asset Securities	6,300	5,000	4,390	-	140,847	103,191
Cash & Short-Term Investments	49,703	40,684	47,460	19,894	237,463	174,862
Cash Growth	85.78%	-14.28%	138.57%	-91.62%	35.80%	58.68%
Accounts Receivable	21,331	24,809	21,389	1,567	21,364	25,170
Other Receivables	2,496	1,607	7,988	9,759	5,682	3,738
Receivables	32,178	34,637	92,306	56,990	176,693	133,983
Inventory	74,268	60,815	61,467	23,257	17,302	17,403
Prepaid Expenses	1,108	847.35	913.48	906.58	135.72	192.19
Other Current Assets	5,101	7,224	9,432	2,052	2,911	2,716
Total Current Assets	162,357	144,207	211,578	103,099	434,504	329,156
Property, Plant & Equipment	360,449	362,959	365,100	314,479	40,186	66,449
Long-Term Investments	1,987	2,447	3,298	54,786	183,574	201,170
Goodwill	-	-	-	-	9.62	9.62
Other Intangible Assets	6,529	7,489	8,431	2,633	3,355	3,358
Long-Term Accounts Receivable	-	-	-	-	21,698	-
Long-Term Deferred Tax Assets	-	-	662.84	-	2,789	-
Long-Term Deferred Charges	44,932	34,625	4,988	-	478	274.3
Other Long-Term Assets	1,417	1,224	5,222	1,904	28,206	46,757
Total Assets	619,901	594,428	599,853	477,646	834,308	647,173
Accounts Payable	5,749	2,734	4,186	3,920	1,421	1,449
Accrued Expenses	2,817	2,556	4,117	8,410	1,092	969.54
Short-Term Debt	35,872	24,026	49,763	398,613	58,600	76,575
Current Portion of Long-Term Debt	45,000	67,542	7,675	-	-	-
Current Portion of Leases	624.46	560.08	934.88	2,785	392.95	225.93
Current Income Taxes Payable	-	-	4.18	-	874.11	-
Current Unearned Revenue	-	-	-	-	152.34	387.55
Other Current Liabilities	29,226	28,222	23,253	8,202	22,562	29,056
Total Current Liabilities	119,289	125,640	89,933	421,929	85,094	108,664
Long-Term Debt	32,000	32,000	31,251	31,046	26,335	7,598
Long-Term Leases	385.64	288.35	571.03	19,925	325.92	554.09
Long-Term Deferred Tax Liabilities	7,611	5,375	5,322	1,167	-	2,147
Other Long-Term Liabilities	2,165	1,696	1,455	309.39	26,315	3,890
Total Liabilities	176,634	176,740	138,851	478,453	144,269	129,638
Common Stock	143,426	132,419	126,834	260,351	91,473	76,863
Additional Paid-In Capital	495,646	472,949	431,641	46,794	347,601	270,595
Retained Earnings	-419,900	-358,604	-293,691	-192,837	-85,366	-39,035
Treasury Stock	-98,115	-98,115	-98,084	-	-3.6	-
Comprehensive Income & Other	1,676	-849.67	48,392	-112,146	-34,727	-38,794
Total Common Equity	122,734	147,800	215,092	2,163	318,978	269,630
Minority Interest	320,533	269,888	245,910	-2,970	371,062	247,906
Shareholders' Equity	443,266	417,688	461,002	-806.44	690,040	517,536
Total Liabilities & Equity	619,901	594,428	599,853	477,646	834,308	647,173
Total Debt	113,882	124,417	90,195	452,369	85,654	84,953
Net Cash (Debt)	-64,180	-83,732	-42,736	-432,475	151,809	89,910
Net Cash Growth	-	-	-	-	68.85%	-
Net Cash Per Share	-256.74	-354.54	-211.16	-2494.46	2684.94	1972.82
Filing Date Shares Outstanding	266.09	244.08	232.93	66.38	60.98	51.24
Total Common Shares Outstanding	266.09	244.08	232.93	66.38	60.98	51.24
Working Capital	43,068	18,567	121,644	-318,829	349,410	220,493
Book Value Per Share	461.24	605.54	923.42	32.59	5230.74	5261.97
Tangible Book Value	116,205	140,311	206,661	-469.92	315,614	266,262
Tangible Book Value Per Share	436.71	574.86	887.23	-7.08	5175.57	5196.25
Land	44,136	44,136	44,190	12,484	13,628	13,628
Buildings	115,847	115,622	113,611	88,041	21,159	20,840
Machinery	258,295	195,122	191,265	137,051	27,204	26,467
Construction In Progress	57,177	107,580	88,234	85,017	1,414	277.8

Source: S&P Capital IQ. Standard template. Financial Sources.